Association "Hepatos Rijeka" is an independent and nongovernmental organization. It was formally established on inaugural meeting on 28.08.2009 with the primary objective of providing assistance to those ill with hepatitis and HIV. It is the only, so far, in the Primorsko-goranska County, whose target groups are primarily infected with hepatitis and HIV and their families
OBJECTIVES OF ACTION
Objectives of action according to statute are: to prevent the development and spread of the disease, to reduce discrimination against people living with hepatitis, HIV and other sexually transmitted diseases and risk behavior groups, to promote better lifestyle, to improve and protect social rights of people living with hepatitis, HIV and other sexually transmitted diseases, their families and social environment and marginalized groups of risky behavior.
The objectives are achieved, among other things, through the following principal activities:
– Counselling and psychosocial support patients treated and ill with hepatitis and HIV, their families and social environment
– Counselling and psychosocial support to people of risky behavior (drug experimenters, drug addicts, prisoners, sex workers, LGBT population, migrants, etc..)
– Improving and developing social and health prevention programs intended for children, youth, adults and marginalized groups of risky behavior
– Promoting understanding of the problem and tolerance for ill people, the protection of human, civil, social, health, labor and other rights of socially vulnerable and ill people, and developing antidiscriminative practices
MISSION
Hepatos Rijeka has a role to inform, educate, publicly advocate and provide expert advice and psychological support.
Values that Hepatos Rijeka advocates are: proactivity in the community, respect for diversity, professionalism, dedication, responsibility, teamwork, efficiency, collaboration, networking, humanity, transparency.
VISION
Hepatos Rijeka will follow its core values; contribute to the development of a more humane and more educated society without prejudice and stigmatization.
PROGRAMS
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close